Recruiting

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.

I'm interested View official listing

ClinicalTrials.gov IDNCT06405828

PhaseNA

Enrollment67

SponsorIcahn School of Medicine at Mount Sinai

Age18 Years and older

SexFEMALE

I'm interested View official listing

Conditions studied

Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7

About this study

Interventions

Behavioral: ACCESS Supportive Care — ACCESS Supportive Care includes: 1. Coaching sessions: 6 one-hour weekly Community Navigator led supportive and early palliative care health coaching sessions. Sessions will be hybrid (in-person or virtual) per participant preference. 2. Monthly check-in: Monthly check-ins (\~5-10 minutes) about their supportive care and social determinants of health needs over 16 weeks. 3. Scheduling of outpatient supportive oncology appointment if interested. 4. Community linkage: Warm hand offs and connection to community resources to enhance access to support groups, educational workshops, and healthy lifestyle services.
Behavioral: Phone sessions — 6 weekly phone sessions, approximately 10 minutes in length each, to review breast cancer and supportive and palliative care resources in NYC and online. The 6 weekly phone sessions will include the topics discussed in the intervention arm but will be informational in nature. The phone sessions will be followed by monthly check-ins (\~5 minutes) to review and answer questions about the resources for the duration of 16 weeks.

Primary outcomes

Number of participants recruited (at 9 months)
Number of participants remaining in study (at 9 months)
Number of times navigator communicates with oncology team (9 months)
Number of times participants connect to resources (9 months)
Number of visits (6 months)
Number of phone calls (9 months)
Number of visits conducted according to the ACCESS manual (9 months)
Change in The Impact of Event Scale - Revised (IES-R) scores (Baseline and 9 months)

Eligibility information

Inclusion Criteria: * Women ≥18 years of age * English and/or Spanish speaking * Self-identify as Latina and/or African American/Black * Ability to understand and the willingness to sign a written informed consent * Stage IV breast cancer diagnosis, no time component Exclusion Criteria: * Moderate to severe cognitive impairment * receiving inpatient hospice care * if patients were previously enrolled in Aim 1 and Aim 2 * currently working with a community navigator

Study locations

Mount Sinai Hospital, New York, New York 10029 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-09.